Combining the small-molecule protein therapy TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) with focused ultrasound (FUS)...

Focused ultrasound therapy provides a non-invasive, promising treatment option for prostate cancer, offering hope with fewer side effects and...

Researchers at UT Southwestern Medical Center have found that a molecule called glial fibrillary acidic protein (GFAP) rises significantly in the...

A new study has shown that artificial intelligence (AI) can significantly reduce the workload for radiologists while maintaining accuracy in...

A large-scale study has found huge variation between GP practices on whether they are likely to pick up prostate cancer using a blood test. The...

Researchers found that methanolic extracts from sweet potato leaves and stems significantly inhibit breast and lung cancer cell growth, with some...

A new research paper published in Oncotarget has highlighted how p53 affects cancer cell growth, treatment resistance, and potential drug targets,...

Testing for PSA protein can indicate whether a man is at risk of prostate cancer.

Clarity Pharmaceuticals will move to the next stage of its phase II trial to test its isotope-based therapy on prostate ...

A pioneering study by scientists from the University of Cyprus and the University of Oxford has uncovered a new cellular mechanism that could lead to...